BI Uses Strados Labs Wearable Monitor in IPF Trial
Boehringer Ingelheim will assess how monitoring cough and crackles with the RESP Biosensor can be used to monitor the status of patients with this disease.
Boehringer Ingelheim will remotely monitor patients using Strados Labs’ FDA-cleared pulmonary wearable device in an upcoming idiopathic pulmonary fibrosis (IPF) pilot study. The Strados RESP Biosensor will be used to monitor cough frequency, severity, and type along with wheezing and other abnormal sounds, such as crackles, IPF patients at home.
Research has suggested that cough may be associated with worse outcomes in pulmonary fibrosis. Boehringer Ingelheim will assess how monitoring cough and crackles with the RESP Biosensor can be used to monitor the status of patients with this disease.
Strados Labs press release.
Aspirin-Free Regimen Lowers Bleeding Events in Patients With Heartmate 3 Heart Pump
December 14th 2023Patients with the HeartMate 3 heart pump for advanced heart failure not taking aspirin as part of their blood-thinning medication regimen had fewer complications from bleeding with lower hospital visits.
BlueRock Therapeutics to Incorporate Wearable and “Invisible” DHT in Parkinson’s Trial
March 16th 2023Rune Labs' StriveStudy platform and Emerald Innovations' Emerald wireless monitoring sensor will passively capture data on Parkinson's disease impact on function of 50 study participants in BlueRock's global non-interventional clinical study.
